VHL and nonpapillary renal cell carcinoma: Their results showed a significant decrease in TAT, VAT, SAT, and TAM in the ccRCC-TTN group compared to the ccRCC-VHL group, establishing a better survival rate for the ccRCC-VHL group than the ccRCC-TTN one [30].